Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Sang T Kim

Showing results (11-20 of 23) with videos related to

Pageof 3
Sort By:
RMD Open|August 30, 2024
Successful management of pre-existing psoriatic arthritis through targeting the IL-23/IL-17 axis in cancer patients receiving immune checkpoint inhibitor therapy: a case seriesYuanteng Jeff Li, Pavlos Msaouel, Matthew Campbell, et al.
Immunotherapy|March 1, 2021
Use of immune checkpoint inhibitors in cancer patients with pre-existing sarcoidosisSang T Kim, Xerxes Pundole, Ramona Dadu, et al.
Journal for Immunotherapy of Cancer|July 8, 2021
Newly developed pseudogout arthritis after therapy with MAGE-A4 directed TCR T cells responded to treatment with tocilizumabSang T Kim, Jean Tayar, Siqing Fu, et al.
Journal for Immunotherapy of Cancer|May 16, 2019
Recurrent pseudogout after therapy with immune checkpoint inhibitors: a case report with immunoprofiling of synovial fluid at each flareSang T Kim, Mohamad Bittar, Hyun J Kim, et al.
Journal of Immunotherapy and Precision Oncology|May 22, 2023
Sarcoidosis and Airway Disease After Immune Checkpoint Inhibitor Therapy: Case Study and Review of the LiteratureFelipe Soto, Luis F Torre-Sada, Frank E Mott, et al.
Frontiers in Immunology|June 13, 2024
Emerging therapeutic options for follicular-derived thyroid cancer in the era of immunotherapyNaimah Turner, Sarah Hamidi, Rim Ouni, et al.
Frontiers in Immunology|February 8, 2021
Distinct Immunophenotypes of T Cells in Bronchoalveolar Lavage Fluid From Leukemia Patients With Immune Checkpoint Inhibitors-Related Pulmonary ComplicationsSang T Kim, Ajay Sheshadri, Vickie Shannon, et al.
Immunohorizons|June 8, 2023
A Nasal Inflammatory Cytokine Signature Is Associated with Early Graft-versus-Host Disease of the Lung after Allogeneic Hematopoietic Cell Transplantation: Proof of ConceptEdwin J Ostrin, Nicholas L Rider, Amin M Alousi, et al.
Frontiers in Immunology|October 16, 2023
Heterogenous lung inflammation CT patterns distinguish pneumonia and immune checkpoint inhibitor pneumonitis and complement blood biomarkers in acute myeloid leukemia: proof of conceptMuhammad Aminu, Naval Daver, Myrna C B Godoy, et al.
Cancer|April 22, 2022
Pneumonitis after immune checkpoint inhibitor therapies in patients with acute myeloid leukemia: A retrospective cohort studyAjay Sheshadri, Alberto A Goizueta, Vickie R Shannon, et al.
Pageof 3

Showing results (11-20 of 23) with videos related to

Sort By:
Pageof 3
RMD Open|August 30, 2024
Successful management of pre-existing psoriatic arthritis through targeting the IL-23/IL-17 axis in cancer patients receiving immune checkpoint inhibitor therapy: a case seriesYuanteng Jeff Li, Pavlos Msaouel, Matthew Campbell, et al.
Immunotherapy|March 1, 2021
Use of immune checkpoint inhibitors in cancer patients with pre-existing sarcoidosisSang T Kim, Xerxes Pundole, Ramona Dadu, et al.
Journal for Immunotherapy of Cancer|July 8, 2021
Newly developed pseudogout arthritis after therapy with MAGE-A4 directed TCR T cells responded to treatment with tocilizumabSang T Kim, Jean Tayar, Siqing Fu, et al.
Journal for Immunotherapy of Cancer|May 16, 2019
Recurrent pseudogout after therapy with immune checkpoint inhibitors: a case report with immunoprofiling of synovial fluid at each flareSang T Kim, Mohamad Bittar, Hyun J Kim, et al.
Journal of Immunotherapy and Precision Oncology|May 22, 2023
Sarcoidosis and Airway Disease After Immune Checkpoint Inhibitor Therapy: Case Study and Review of the LiteratureFelipe Soto, Luis F Torre-Sada, Frank E Mott, et al.
Frontiers in Immunology|June 13, 2024
Emerging therapeutic options for follicular-derived thyroid cancer in the era of immunotherapyNaimah Turner, Sarah Hamidi, Rim Ouni, et al.
Frontiers in Immunology|February 8, 2021
Distinct Immunophenotypes of T Cells in Bronchoalveolar Lavage Fluid From Leukemia Patients With Immune Checkpoint Inhibitors-Related Pulmonary ComplicationsSang T Kim, Ajay Sheshadri, Vickie Shannon, et al.
Immunohorizons|June 8, 2023
A Nasal Inflammatory Cytokine Signature Is Associated with Early Graft-versus-Host Disease of the Lung after Allogeneic Hematopoietic Cell Transplantation: Proof of ConceptEdwin J Ostrin, Nicholas L Rider, Amin M Alousi, et al.
Frontiers in Immunology|October 16, 2023
Heterogenous lung inflammation CT patterns distinguish pneumonia and immune checkpoint inhibitor pneumonitis and complement blood biomarkers in acute myeloid leukemia: proof of conceptMuhammad Aminu, Naval Daver, Myrna C B Godoy, et al.
Cancer|April 22, 2022
Pneumonitis after immune checkpoint inhibitor therapies in patients with acute myeloid leukemia: A retrospective cohort studyAjay Sheshadri, Alberto A Goizueta, Vickie R Shannon, et al.
Pageof 3